{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:27:50Z","timestamp":1793795270934,"version":"4.6.1"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/neuros\/nyy121","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T16:11:48Z","timestamp":1520871108000},"page":"1107-1118","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":79,"title":["Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease"],"prefix":"10.1227","volume":"83","author":[{"given":"Keith","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Qualmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshua","family":"Esquenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20250131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol Clin"},{"key":"R2-2-20250131","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"R3-2-20250131","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2011.2.FOCUS1116","article-title":"The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments","volume":"30","author":"Choy","year":"2011","journal-title":"Neurosurg Focus"},{"key":"R4-2-20250131","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas","volume":"6","author":"Ruttledge","year":"1994","journal-title":"Nat Genet"},{"key":"R5-2-20250131","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"R6-2-20250131","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi","year":"2016","journal-title":"Neuro Oncol"},{"key":"R7-2-20250131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02688690500081206","article-title":"Management of the patient and family with neurofibromatosis 2: A consensus conference statement","volume":"19","author":"Evans","year":"2005","journal-title":"Br J Neurosurg"},{"key":"R8-2-20250131","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"key":"R9-2-20250131","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"R10-2-20250131","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L","volume":"101","author":"Rong","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-2-20250131","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.molmed.2015.01.003","article-title":"Disease implications of the Hippo\/YAP pathway","volume":"21","author":"Plouffe","year":"2015","journal-title":"Trends Mol Med"},{"key":"R12-2-20250131","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","article-title":"Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin","volume":"177","author":"Curto","year":"2007","journal-title":"J Cell Biol"},{"key":"R13-2-20250131","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/(SICI)1097-4547(19961201)46:5<595::AID-JNR8>3.0.CO;2-E","article-title":"Expression of the neurofibromatosis 2 tumor supp-ressor gene product, merlin, in schwann cells","volume":"46","author":"Scherer","year":"1996","journal-title":"J Neurosci Res"},{"key":"R14-2-20250131","doi-asserted-by":"crossref","first-page":"8815","DOI":"10.1038\/sj.onc.1208110","article-title":"Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2","volume":"23","author":"Wiederhold","year":"2004","journal-title":"Oncogene"},{"key":"R15-2-20250131","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM196005052621803","article-title":"Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib","volume":"262","author":"Gorlin","year":"1960","journal-title":"N Engl J Med"},{"key":"R16-2-20250131","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-3-32","article-title":"Nevoid basal cell carcinoma syndrome (gorlin syndrome)","volume":"3","author":"Lo Muzio","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"R17-2-20250131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet"},{"key":"R18-2-20250131","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/jnnp.47.2.210","article-title":"Basal cell naevus syndrome and intracranial meningioma","volume":"47","author":"Mortimer","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-2-20250131","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.GIM.0000145045.17711.1C","article-title":"Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or gorlin) syndrome","volume":"6","author":"Kimonis","year":"2004","journal-title":"Genet Med"},{"key":"R20-2-20250131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am J Med Genet"},{"key":"R21-2-20250131","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0140-6736(92)90868-4","article-title":"Location of gene for gorlin syndrome","volume":"339","author":"Farndon","year":"1992","journal-title":"Lancet"},{"key":"R22-2-20250131","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jmedgenet-2017-104669","article-title":"First evidence of genotype-phenotype correlations in Gorlin syndrome","volume":"54","author":"Evans","year":"2017","journal-title":"J Med Genet"},{"key":"R23-2-20250131","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1158\/0008-5472.CAN-07-5092","article-title":"The Smo\/Smo model: Hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread","volume":"68","author":"Hatton","year":"2008","journal-title":"Cancer Res"},{"key":"R24-2-20250131","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","article-title":"Basal cell carcinomas: Attack of the hedgehog","volume":"8","author":"Epstein","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R25-2-20250131","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.devcel.2016.07.026","article-title":"Hedgehog signal transduction: Key players, oncogenic drivers, and cancer therapy","volume":"38","author":"Pak","year":"2016","journal-title":"Dev Cell"},{"key":"R26-2-20250131","doi-asserted-by":"crossref","first-page":"907543","DOI":"10.1155\/2012\/907543","article-title":"Patched knockout mouse models of Basal cell carcinoma","volume":"2012","author":"Nitzki","year":"2012","journal-title":"J Skin Cancer"},{"key":"R27-2-20250131","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.277.5329.1109","article-title":"Altered neural cell fates and medulloblastoma in mouse patched mutants","volume":"277","author":"Goodrich","year":"1997","journal-title":"Science"},{"key":"R28-2-20250131","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: Paradigms and principles","volume":"15","author":"Ingham","year":"2001","journal-title":"Genes Dev"},{"key":"R29-2-20250131","first-page":"181","article-title":"Hedgehog beyond medulloblastoma and basal cell carcinoma","volume":"1805","author":"Teglund","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R30-2-20250131","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10689-012-9548-0","article-title":"Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation","volume":"11","author":"Kijima","year":"2012","journal-title":"Familial Cancer"},{"key":"R31-2-20250131","first-page":"345","article-title":"SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas","volume":"19","author":"Boetto","year":"2017","journal-title":"Neuro Oncol"},{"key":"R32-2-20250131","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajhg.2012.07.015","article-title":"Loss of SUFU function in familial multiple meningioma","volume":"91","author":"Aavikko","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R33-2-20250131","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ejhg.2008.162","article-title":"PTEN hamartoma tumor syndromes","volume":"16","author":"Blumenthal","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"R34-2-20250131","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the real cowden syndrome please stand up: revised diagnostic criteria","volume":"37","author":"Eng","year":"2000","journal-title":"J Med Genet"},{"key":"R35-2-20250131","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1399-0004.1986.tb00816.x","article-title":"The cowden syndrome: A clinical and genetic study in 21 patients","volume":"29","author":"Starink","year":"1986","journal-title":"Clin Genet"},{"key":"R36-2-20250131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.ejhg.5200289","article-title":"Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations","volume":"7","author":"Nelen","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"R37-2-20250131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.18632\/oncoscience.305","article-title":"Hidden association of cowden syndrome, PTEN mutation and meningioma frequency","volume":"3","author":"Yakubov","year":"2016","journal-title":"Oncoscience"},{"key":"R38-2-20250131","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2230.2008.02846.x","article-title":"Proteus syndrome complicated by multiple spinal meningiomas","volume":"33","author":"Asahina","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"R39-2-20250131","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/1096-8628(20000731)93:3<234::AID-AJMG15>3.0.CO;2-9","article-title":"Multiple meningiomas, craniofacial hyperostosis and retinal abnormalities in proteus syndrome","volume":"93","author":"Gilbert-Barness","year":"2000","journal-title":"Am J Med Genet"},{"key":"R40-2-20250131","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R41-2-20250131","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"R42-2-20250131","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1158\/0008-5472.CAN-06-0712","article-title":"High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model","volume":"66","author":"Wei","year":"2006","journal-title":"Cancer Res"},{"key":"R43-2-20250131","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1158\/0008-5472.CAN-07-6867","article-title":"Pten haploinsufficiency accelerates formation of high-grade astrocytomas","volume":"68","author":"Kwon","year":"2008","journal-title":"Cancer Res"},{"key":"R44-2-20250131","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/hmg\/10.6.605","article-title":"PTEN inhibits insulin-stimulated MEK\/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1\/Grb-2\/Sos complex formation in a breast cancer model","volume":"10","author":"Weng","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R45-2-20250131","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1126\/science.280.5369.1614","article-title":"Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN","volume":"280","author":"Tamura","year":"1998","journal-title":"Science"},{"key":"R46-2-20250131","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-4608(98)00209-X","article-title":"Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas","volume":"110","author":"Lamszus","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"R47-2-20250131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2990.1998.00093.x","article-title":"Analysis of the PTEN gene in human meningiomas","volume":"24","author":"Peters","year":"1998","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R48-2-20250131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"R49-2-20250131","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1038\/onc.2008.170","article-title":"AKT1(E17K) in human solid tumours","volume":"27","author":"Bleeker","year":"2008","journal-title":"Oncogene"},{"key":"R50-2-20250131","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi","year":"2016","journal-title":"Neuro Oncol"},{"key":"R51-2-20250131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00005792-196605000-00001","article-title":"A review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process","volume":"45","author":"Epstein","year":"1966","journal-title":"Medicine"},{"key":"R52-2-20250131","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.272.5259.258","article-title":"Positional cloning of the Werner's syndrome gene","volume":"272","author":"Yu","year":"1996","journal-title":"Science"},{"key":"R53-2-20250131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1447-0594.2012.00913.x","article-title":"Diagnostic criteria for werner syndrome based on japanese nationwide epidemiological survey","volume":"13","author":"Takemoto","year":"2013","journal-title":"Geriatr Gerontol Int"},{"key":"R54-2-20250131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/humu.23128","article-title":"WRN mutation update: mutation spectrum, patient registries, and translational prospects","volume":"38","author":"Yokote","year":"2017","journal-title":"Human Mutat"},{"key":"R55-2-20250131","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(98)05869-3","article-title":"Prevalence of Werner's syndrome heterozygotes in Japan","volume":"353","author":"Satoh","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"R56-2-20250131","doi-asserted-by":"crossref","first-page":"e59709","DOI":"10.1371\/journal.pone.0059709","article-title":"Spectrum and risk of neoplasia in werner syndrome: a systematic review.","volume":"8","author":"Lauper","year":"2013","journal-title":"PLoS One"},{"key":"R57-2-20250131","first-page":"239","article-title":"Excess of rare cancers in werner syndrome (adult progeria)","volume":"5","author":"Goto","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R58-2-20250131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.str.2009.12.011","article-title":"Structural basis for DNA strand separation by the unconventional winged-helix domain of RecQ helicase WRN","volume":"18","author":"Kitano","year":"2010","journal-title":"Structure"},{"key":"R59-2-20250131","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev-biochem-060713-035428","article-title":"Human RecQ helicases in DNA repair, recombination, and replication","volume":"83","author":"Croteau","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"R60-2-20250131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jcp.1041620213","article-title":"Regulation of c-fos expression in senescing werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors","volume":"162","author":"Oshima","year":"1995","journal-title":"J Cell Physiol"},{"key":"R61-2-20250131","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000056841","article-title":"Spectral karyotyping of werner syndrome fibroblast cultures","volume":"91","author":"Melcher","year":"2000","journal-title":"Cytogenet Genome Res"},{"key":"R62-2-20250131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.arr.2016.03.002","article-title":"Werner Syndrome: Clinical Features, Pathogenesis and Potential Therapeutic Interventions","volume":"33","author":"Oshima","year":"2017","journal-title":"Ageing research reviews"},{"key":"R63-2-20250131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fsurg.2016.00040","article-title":"Meningioma genomics: diagnostic, prognostic, and therapeutic applications","volume":"3","author":"Bi","year":"2016","journal-title":"Front Surg"},{"key":"R64-2-20250131","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","article-title":"Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications","volume":"60","author":"Cai","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"R65-2-20250131","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression","volume":"94","author":"Weber","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R66-2-20250131","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3892\/etm.2015.2519","article-title":"Methylation of werner syndrome protein is associated with the occurrence and development of invasive meningioma via the regulation of myc and p53 expression","volume":"10","author":"Li","year":"2015","journal-title":"Exp Ther Med"},{"key":"R67-2-20250131","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1073\/pnas.0600645103","article-title":"Epigenetic inactivation of the premature aging werner syndrome gene in human cancer","volume":"103","author":"Agrelo","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R68-2-20250131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"R70-2-20250131","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0959-8049(97)89007-7","article-title":"Tumour biological features of BRCA1-induced breast and ovarian cancer","volume":"33","author":"Johannsson","year":"1997","journal-title":"Eur J Cancer"},{"key":"R71-2-20250131","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"R72-2-20250131","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/neuonc\/nox094","article-title":"Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol"},{"key":"R73-2-20250131","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.2552","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","author":"Smith","year":"2013","journal-title":"Nat Genet"},{"key":"R74-2-20250131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10048-015-0472-y","article-title":"A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening","volume":"17","author":"Gerkes","year":"2016","journal-title":"Neurogenetics"},{"key":"R75-2-20250131","doi-asserted-by":"crossref","first-page":"22656","DOI":"10.1074\/jbc.M602561200","article-title":"The SWI\/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells","volume":"281","author":"Garcia-Pedrero","year":"2006","journal-title":"J Biol Chem"},{"key":"R76-2-20250131","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2009.06005.x","article-title":"N-terminally truncated BAF57 isoforms contribute to the diversity of SWI\/SNF complexes in neurons","volume":"109","author":"Kazantseva","year":"2009","journal-title":"J Neurochem"},{"key":"R77-2-20250131","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1128\/MCB.25.18.7953-7965.2005","article-title":"The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene","volume":"25","author":"Wang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R79-2-20250131","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/his.13135","article-title":"SMARCE1 mutation screening in classification of clear cell meningiomas","volume":"70","author":"Smith","year":"2017","journal-title":"Histopathology"},{"key":"R81-2-20250131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10048-012-0319-8","article-title":"Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis","volume":"13","author":"Smith","year":"2012","journal-title":"Neurogenetics"},{"key":"R82-2-20250131","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/jmg.2007.056499","article-title":"Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis","volume":"45","author":"Hadfield","year":"2008","journal-title":"J Med Genet"},{"key":"R83-2-20250131","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/513207","article-title":"Germline mutation of INI1\/SMARCB1 in familial schwannomatosis","volume":"80","author":"Hulsebos","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R84-2-20250131","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1086\/302639","article-title":"Constitutional mutations of the hSNF5\/INI1 gene predispose to a variety of cancers","volume":"65","author":"Sevenet","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R85-2-20250131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10048-009-0204-2","article-title":"Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation","volume":"11","author":"Bacci","year":"2010","journal-title":"Neurogenetics"},{"key":"R86-2-20250131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-011-0300-y","article-title":"Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri","volume":"13","author":"van den Munckhof","year":"2012","journal-title":"Neurogenetics"},{"key":"R87-2-20250131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1054\/bjoc.2000.1583","article-title":"INI1 mutations in meningiomas at a potential hotspot in exon 9","volume":"84","author":"Schmitz","year":"2001","journal-title":"Br J Cancer"},{"key":"R88-2-20250131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/mp.56.5.299","article-title":"Molecular heterogeneity of meningioma with INI1 mutation","volume":"56","author":"Rieske","year":"2003","journal-title":"Mol Pathol"},{"key":"R89-2-20250131","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","article-title":"Meningiomas may be a component tumor of multiple endocrine neoplasia type 1","volume":"10","author":"Asgharian","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R90-2-20250131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3171\/jns.2005.102.1.0167","article-title":"Multiple meningiomas in a patient with Rubinstein-Taybi syndrome","volume":"102","author":"Verstegen","year":"2005","journal-title":"J Neurosurg"},{"key":"R91-2-20250131","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R92-2-20250131","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006123-201812000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:53:14Z","timestamp":1786121594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201812000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyy121","relation":{},"ISSN":["0148-396X"],"issn-type":[{"value":"0148-396X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}